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196a Monday, March 7, 2011simulations of membrane-embedded solutes has, in general, been drastically
underestimated.
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Theproperdescriptionof the electric environment ofmacromolecules is a critical
challenge for force field methods. To test and validate the CHARMM force
field’s ability to describe this electric environment combined QM/MM calcula-
tions have been used to calculate the vibrational Stark effect (VSE). The Stark
effect refers to the characteristic shift of a specific vibrational frequency upon
the introduction of an electric field. In this work, we develop a first principles
methodology to compute Stark shifts using correlated electronic structure tech-
niques and validate this approach by computing the Stark shift of a model VSE
probe, acetonitrile, in several solvents. The solvent environment around the
probe is sampled through 20 ns molecular dynamics simulations of each mole-
cule surrounded by several hundred explicit solvent molecules. From these sim-
ulations, two hundred snapshots of the probe with the solvent environment are
collected for the QM/MM analysis. Several QM/MM computational schemes
are compared for calculating the vibrational spectrum of the VSE probe in the
field created by the solvent molecules, which are treated as MM atoms with
theCHARMMforce field. From these computations, an average Stark shift is de-
termined for each probemolecule and compared to experimentalmeasurements.
This information can be directly related to the electric field surrounding the probe
molecule, and thereforemaybe used as a direct test of the ability of a force field to
reproduce the electric field around those functional groups. Information from
these calculations will act as the basis for additional optimization of the force
field to more accurately represent the electric fields in macromolecules.
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Recently Virus-like-Particles (VLPs) have been used as vaccines against viral
diseases. It is the structural similarity of VLPs, and the surface proteins (epi-
topes) that evokes a neutralizing antibody response. We present a novel com-
putational approach which may ultimately be applied in cell-free synthesis of
VLP-based vaccines that are stable over wide range of external environmental
conditions (e.g. temperature). Moreover, we aim to construct VLPs that can be
stored and dressed later with different epitopes depending on the target virus,
addressing wide range of viral diseases in a fast, cost-effective manner in un-
folding pandemic scenarios.
Here we present computational studies on VLPs constructed from a major cap-
sid protein (L1) of human papilloma virus (HPV). The thermal stability and
structural dynamics of these VLPs was studied using our novel multiscale
all-atom approach. We probed mechanical stability via a bottom-up approach
starting from major L1 protein going eventually up to the complete VLPs. Ex-
ternal force was applied to each of these systems to probe their response to ex-
ternal tension. We have found the unfolding pathways of L1 proteins. Forces
were applied to probe the strength of interface interactions between (1) L1 pro-
teins and (2) pentameric assemblies of these protomers that form the subunits of
a complete VLP. Finally we performed fully atomistic force-probe MD simu-
lations of the complete VLPs in explicit solvent. Forces were applied at differ-
ent positions on the viral surface. A detailed picture of the spatial distribution of
elastic constants and yielding forces was obtained.
All these results together helped us to understand thermal, chemical and me-
chanical stability of HPVVLPs. These will be used to make appropriate predic-
tions of mutations in the structures to achieve our long term goal of constructing
more stable VLPs.
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Mutations in the human Ether-a`-go-go related gene (hERG) potassium channel
and hERG channel blockers offer tools for studying structural, biophysical and
functional properties of the channel. However, the current understanding of
how the hERG channel opens and closes is still incomplete. Here, we used al-
ternative chemical tools, hERG channel enhancers, to study the hERG channelgating. RPR260243 drastically slowed down the deactivation rate whereas
NS-1643 accelerated the activation rate. Neither enhancers changed the open
probability of the inactivation gate. In contrast, PD-307243 only affected the
inactivation by positively shifting its open probability curve without changing
the activation properties. Because these enhancers have been shown to have
different binding sites, we hypothesized that a novel binding site might exist
for previously unrecognized hERG channel blockers. By using substructures
of the 3 hERG channel enhancers for a cheminformatics search, we discovered
several Novartis hERG blockers that likely overlap with the enhancer binding
sites. These findings demonstrate the possible utilization of hERG channel
enhancers to explore channel biophysics and uncover different classes of novel
hERG channel blockers that may escape from traditional detection methods
such as dofetilide-related radioligand binding.
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Automated planar patch clamp devices, with their higher throughput and high
data information content, are finding their place in the market for making high
quality electrophysiological measurements.
Ease of use and higher data throughput make these devices ideal tools for ion
channel screening and safety testing. The ability to record from stem cell de-
rived cardiomyocytes in both voltage and current clamp modes on an auto-
mated patch clamp platform is an important advancement in ion channel
screening and safety testing. Using a planar patch clamp workstation, currents
mediated by Kþ, Naþ and Ca2þ channels could be recorded from stem cell
derived cardiomyocytes in the voltage clamp mode. In the current clamp
mode, action potentials could be recorded for the first time on a planar patch
clamp device. The built-in temperature control allowed for pharmacology on
action potentials (see figure)
both at room temperature
and 35.
The use of stem cell derived
cardiomyocytes in safety
testing is becoming increas-
ingly important. The ability
to test compounds on ion
channels in both voltage and
current clamp modes, as
well as at different tempera-
tures, may be crucial for fu-
ture safety testing.1076-Plat
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The Ca2þ binding protein STIM1 is located primarily in the sarcoplasmic and en-
doplasmic reticulum. It is thought that STIM1 plays a critical role in activating
Ca2þ release activated Ca2þ channel (CRAC) in non-excitable cells such as
T lymphocytes and may also be important in excitable cells such as skeletal mus-
cle and smoothmuscle cells.However, it is not clear yet if STIM1 is expressed and
functions in adult rat ventricular myocytes. Figure A shows STIM1 immunofluo-
rescence and Figure B shows STIM1-mcherry fluorescence expressed in cultured
rat ventricular myocytes. Both show a similar pattern of STIM1 localization,
primarily at the Z-disk of the ventricular myocyte. Fluorescence recovery
after photobleaching shows that STIM1 moves readily with the S/ER network.
While there is no obvious need for store-operated Ca2þ channels (SOCs) in ven-
tricular myocytes, the clear
presence of STIM1 suggests
that an as yet undiscovered
function of this Ca2þ bind-
ing protein in ventricular
myocytes is likely to be
discovered. We are now ex-
amining the electrophysio-
logical and Ca2þ signaling
functions of STIM1 inmam-
malian (rat and mouse) ven-
tricular myocytes.
